title: Chronic progressive interstitial fibrosis in renal disease--are there novel pharmacological approaches?
authors.forename: M
authors.initials: M
authors.lastname: Fukagawa
authors.forename: M
authors.initials: M
authors.lastname: Noda
authors.forename: T
authors.initials: T
authors.lastname: Shimizu
authors.forename: K
authors.initials: K
authors.lastname: Kurokawa
mesh_terms: D000818:Animals; D002908:Chronic Disease; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D005355:Fibrosis; D006801:Humans; D007668:Kidney / Q000473:pathology*; D011728:Pyridones / Q000627:therapeutic use*; D012084:Renin-Angiotensin System / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D016326:Extracellular Matrix Proteins; D011728:Pyridones; D014409:Tumor Necrosis Factor-alpha; C093844:pirfenidone